Navigation Links
Point-of-Delivery Drug. Reconstitution Systems Markets, Strategies and Prospects
Date:3/14/2013

DUBLIN, Ireland, March 14, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Point-of-Delivery Drug. Reconstitution Systems Markets, Strategies and Prospects" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Growth in the number of injectable drugs supplied in solid form for reconstitution prior to administration is being driven by the increase in drugs based on biological NCEs. These drugs are typically unstable at ambient temperatures and to preserve their shelf life must be either stored at low temperature (the so-call 'cold chain') or processed into a form that will preserve their pharmacological efficacy until they reach their therapeutic destination.

Because the cost of transporting and storing drugs using refrigeration is expensive and requires constant temperature monitoring to insure that the drug has not been exposed to environmental conditions that render unsafe for use as a therapeutic product, technologies such as lyophilization are becoming more prevalent.

The packaging and technologies developed and marketed for safe and reliable reconstitution at the point of administration are benefiting from this market trend. This report examines commercial drug reconstitution devices and systems and their impact on the injectable drug delivery sector.


Highlights

- Analyzes therapeutic demand drivers and evaluates the market impact and potential of commercial drug reconstitution systems

- Provides analysis of injectable drugs for reconstitution and assesses key market segments, market dynamics and market demographics

- Forecasts Injectable drug product demand by indication and therapy to 2017

-Profiles reconstitution system suppliers, their product activities, business strategies, and corporate alliances and affiliations

Topics Covered

Executive Summary

Market Dynamics

What's Driving the Growth in Engineered Reconstitution Systems?

Drug Reconstitution Systems - Commercial Devices

Drug Reconstitution - Therapeutic Sector Analysis

Market Factors

Drug Reconstitution Systems - Company Profiles

For more information and a full list of topics covered visit http://www.researchandmarkets.com/research/8qmbbz/pointofdelivery

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems
2. Clionsky Neuro Systems (CNS-Neuro) Announces Publication of Study Finding Elderly Patients Unable to Recognize Their Memory Loss
3. Dicom Systems and USARAD.com Announce Partnership and Introduce Beta Version of XMRI.com, New System by USARAD.com
4. BioPower Systems Awarded $5 Million from Victorian Government
5. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
6. Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology
7. CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems
8. MarketsandMarkets: Global Clinical Trial Management Systems Market Worth $1300.4 Million by 2016
9. A new class of electron interactions in quantum systems
10. AMPAC Fine Chemicals Continues to Invest in Quality Systems
11. Chemring Detection Systems Awarded $500k for Strategic Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... , ... August 23, 2017 , ... NDA Partners Chairman ... Director of the Office of Device Evaluation at the FDA’s Center for Devices and ... joined the firm as an Expert Consultant. , Prior to his FDA experience, Dr. ...
(Date:8/22/2017)... ... August 22, 2017 , ... One of the biggest ... of opioid-dose sparing. Opioid-dose sparing refers to the reduction of opioid dosage by ... anti-inflammatory drugs (NSAIDs). , The potential for new therapies to replace opioids and/or ...
(Date:8/21/2017)... , ... August 21, 2017 , ... ... the Big Island of Hawaii, is pleased to announce the first Delos Wellness ... of MacArthur Sotheby’s International Realty is working together with listing agent Kelly Allen, ...
(Date:8/21/2017)... MA (PRWEB) , ... August 21, 2017 , ... ... consulting firm is utilizing its extensive experience with Health Economics and Outcomes Research ... Electronic Health Record data. In 2014, US healthcare spending exceeded $3.0 trillion with ...
Breaking Biology Technology:
(Date:8/15/2017)... Va. , Aug. 15 2017   ivWatch LLC , ... of intravenous (IV) therapy, today announced receipt of its ISO 13485 ... developed by the International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the ... "This is ...
(Date:6/30/2017)... Today, American Trucking Associations announced Seeing ... and eye tracking software, became the newest member ... "Artificial intelligence and advanced sensing algorithms ... driver,s attentiveness levels while on the road.  Drivers ... fatigue and prevent potential accidents, which could lead ...
(Date:6/14/2017)... PARIS , June 15, 2017  IBM (NYSE: IBM ... the international tech event dedicated to developing collaboration between startups ... on June 15-17. During the event, nine startups will ... deliver value in various industries. ... in the international market, with a 30 percent increase in ...
Breaking Biology News(10 mins):